ARTEMISMED Stock Overview
Engages in the management and operation of multi specialty hospitals in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
No risks detected for ARTEMISMED from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Artemis Medicare Services Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹331.25 |
| 52 Week High | ₹347.70 |
| 52 Week Low | ₹141.30 |
| Beta | 0.79 |
| 1 Month Change | 18.28% |
| 3 Month Change | 17.97% |
| 1 Year Change | 90.59% |
| 3 Year Change | 774.01% |
| 5 Year Change | n/a |
| Change since IPO | 1,367.33% |
Recent News & Updates
Recent updates
Artemis Medicare Services Limited Recorded A 5.3% Miss On Revenue: Analysts Are Revisiting Their Models
Nov 18
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Artemis Medicare Services Limited's (NSE:ARTEMISMED) CEO For Now
Jul 18Artemis Medicare Services Limited's (NSE:ARTEMISMED) P/E Is Still On The Mark Following 31% Share Price Bounce
Jul 16After Leaping 27% Artemis Medicare Services Limited (NSE:ARTEMISMED) Shares Are Not Flying Under The Radar
Apr 13Artemis Medicare Services (NSE:ARTEMISMED) Has A Pretty Healthy Balance Sheet
Jun 14Artemis Medicare Services (NSE:ARTEMISMED) Has A Somewhat Strained Balance Sheet
Mar 15Capital Allocation Trends At Artemis Medicare Services (NSE:ARTEMISMED) Aren't Ideal
Aug 31Is Artemis Medicare Services (NSE:ARTEMISMED) A Risky Investment?
Jul 30Artemis Medicare Services (NSE:ARTEMISMED) Is Reinvesting At Lower Rates Of Return
May 13Returns On Capital At Artemis Medicare Services (NSE:ARTEMISMED) Paint A Concerning Picture
Jan 11Artemis Medicare Services (NSE:ARTEMISMED) Has A Pretty Healthy Balance Sheet
Dec 10There Are Reasons To Feel Uneasy About Artemis Medicare Services' (NSE:ARTEMISMED) Returns On Capital
Sep 11Artemis Medicare Services (NSE:ARTEMISMED) Has A Somewhat Strained Balance Sheet
Jul 01There Are Reasons To Feel Uneasy About Artemis Medicare Services' (NSE:ARTEMISMED) Returns On Capital
May 11We Think Artemis Medicare Services (NSE:ARTEMISMED) Is Taking Some Risk With Its Debt
Mar 16Is Artemis Medicare Services (NSE:ARTEMISMED) Likely To Turn Things Around?
Jan 22Is Artemis Medicare Services (NSE:ARTEMISMED) A Risky Investment?
Nov 13Market Still Lacking Some Conviction On Artemis Medicare Services Limited (NSE:ARTEMISMED)
Jul 20Shareholder Returns
| ARTEMISMED | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | -1.5% | -0.08% | -1.9% |
| 1Y | 90.6% | 46.5% | 24.7% |
Return vs Industry: ARTEMISMED exceeded the Indian Healthcare industry which returned 43.5% over the past year.
Return vs Market: ARTEMISMED exceeded the Indian Market which returned 22.5% over the past year.
Price Volatility
| ARTEMISMED volatility | |
|---|---|
| ARTEMISMED Average Weekly Movement | 6.2% |
| Healthcare Industry Average Movement | 5.7% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.1% |
Stable Share Price: ARTEMISMED has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: ARTEMISMED's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 1,991 | Devlina Chakravarty | www.artemishospitals.com |
Artemis Medicare Services Limited engages in the management and operation of multi specialty hospitals in India and internationally. The company offers medical and surgical intervention; and inpatient and outpatient services. It also operates Artemis Hospital, a multi-specialty hospital located in Gurugram.
Artemis Medicare Services Limited Fundamentals Summary
| ARTEMISMED fundamental statistics | |
|---|---|
| Market cap | ₹45.58b |
| Earnings (TTM) | ₹646.58m |
| Revenue (TTM) | ₹9.09b |
70.5x
P/E Ratio5.0x
P/S RatioIs ARTEMISMED overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ARTEMISMED income statement (TTM) | |
|---|---|
| Revenue | ₹9.09b |
| Cost of Revenue | ₹7.11b |
| Gross Profit | ₹1.97b |
| Other Expenses | ₹1.33b |
| Earnings | ₹646.58m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 4.70 |
| Gross Margin | 21.71% |
| Net Profit Margin | 7.12% |
| Debt/Equity Ratio | 32.0% |
How did ARTEMISMED perform over the long term?
See historical performance and comparisonDividends
0.1%
Current Dividend Yield12%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/18 02:28 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Artemis Medicare Services Limited is covered by 1 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Sumit Gupta | Centrum Broking Limited |